Psoriasis was initially thought to be a IFNγ related disease but more recent studies—and the success of biologics targeting the IL-17 pathway—indicate a more dominant role for TNFα and IL-17 driven disease (1, 135, 136). This evidence concerns the gene IL17A and psoriasis.